Exelon (EXC) Director Acquires 954 Shares at $43.25 – Form 4 Filing

Form 4 insider activity – Exelon Corporation (EXC): On 06/30/2025 director Bryan K. Segedi acquired 954 deferred stock units of Exelon common stock at $43.25 each through the Exelon Corp. Directors Deferred Stock Unit Plan.

Rhea-AI Filing Summary

Form 4 insider activity – Exelon Corporation (EXC): On 06/30/2025 director Bryan K. Segedi acquired 954 deferred stock units of Exelon common stock at $43.25 each through the Exelon Corp. Directors Deferred Stock Unit Plan. The purchase increased his indirect holdings to 6,483 units, a figure that already includes 51 shares accumulated via dividend reinvestment. No shares were sold and no derivative positions were reported.

The transaction is valued at roughly $41k, immaterial to Exelon’s overall share count, but may signal incremental insider confidence. There are no indications of significant strategic shifts, option exercises, or complex hedging instruments in this filing.

Insights

Securities Analyst

TL;DR – Small insider buy; minimal direct impact on valuation.

Segedi’s purchase of 954 deferred stock units is financially modest for a multi-billion-dollar utility like Exelon, representing well under 0.01 % of shares outstanding. Because the units were acquired under a standing director compensation plan, the filing largely reflects routine equity accrual rather than an opportunistic open-market buy. While insider alignment is generally viewed positively, the scale makes the event neutral for most valuation models and unlikely to move the stock.

Corporate Governance Expert

TL;DR – Routine deferred stock grant, underscores board equity alignment.

The deferred stock unit plan channels a portion of director compensation into equity, aligning board interests with shareholders over the long term. Segedi’s holdings now stand at 6,483 units, a reasonable stake that encourages oversight without granting outsized influence. Absence of sales or derivative activity removes potential conflict signals. Governance-wise, the filing is standard and non-controversial.

Insider Trade Summary

Grant/Award: 954 shares

Grant/Award 1 txn

Insider Segedi Bryan K

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common stock- deferred stock units	954	$43.25	$41K

Holdings After Transaction: Common stock- deferred stock units — 6,483 shares (Indirect, By Exelon Corp. Directors Deferred Stock Unit Plan)

Footnotes (1)

1. F1. Balance includes 51 additional shares acquired through automatic dividend reinvestment.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Exelon (EXC) shares did director Bryan Segedi acquire?

He acquired 954 deferred stock units on 06/30/2025.

At what price were the deferred stock units acquired?

The units were recorded at $43.25 per share.

What is Bryan Segedi’s total indirect ownership after the transaction?

He now indirectly holds 6,483 deferred stock units via the director plan.

Does the Form 4 show any insider sales or option exercises?

No, the filing reports only an acquisition; there were no sales or derivative exercises.

Why are these units recorded as indirect ownership?

The shares reside within the Exelon Corp. Directors Deferred Stock Unit Plan, classifying them as indirect holdings.

Is this insider purchase material to Exelon’s share count?

No, the 954 units are immaterial relative to Exelon’s large outstanding share base.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2025 - 09:41 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Segedi Bryan K

(Last) (First) (Middle)

10 S DEARBORN STREET

54TH FLOOR

(Street)

CHICAGO IL 60603

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EXELON CORP [ EXC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock- deferred stock units	06/30/2025		A		954	A	$43.25	6,483(1)	I	By Exelon Corp. Directors Deferred Stock Unit Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Balance includes 51 additional shares acquired through automatic dividend reinvestment.

Remarks:

	David T Skinner, attorney-in-fact for Bryan K Segedi	07/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.